Correction to: Aspartate Aminotransferase to Platelet Ratio and Fibrosis-4 as Biomarkers in Biopsy-Validated Pediatric Cystic Fibrosis Liver Disease ((2015), 62, (1576-1583), 10.1002/hep.28016);Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease

Hepatology

Volumn 62, Issue 5, 2015, Pages 1576-1583

  Leung, Daniel H ^a,b   Khan, Mahjabeen ^b   Minard, Charles G ^a   Guffey, Danielle ^a   Ramm, Louise E ^c   Clouston, Andrew D ^d   Miller, Gregory ^d   Lewindon, Peter J ^c,e   Shepherd, Ross W ^a,b,c   Ramm, Grant A ^c,d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Texas Childrens Cancer Center   (United States)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE TO PLATELET RATIO INDEX; CHILD; CHILDHOOD DISEASE; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS LIVER DISEASE; DIGESTIVE SYSTEM DISEASE ASSESSMENT; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; FIBROSIS 4 INDEX; HEPATOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PH; PORTAL HYPERTENSION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCHOOL CHILD; SPLENOMEGALY; THROMBOCYTE COUNT; VALIDATION STUDY; BIOPSY; BLOOD; COMPLICATION; LIVER; LIVER CIRRHOSIS; PATHOLOGY; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADOLESCENT; ASPARTATE AMINOTRANSFERASES; BIOMARKERS; BIOPSY; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; PLATELET COUNT; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84945191347     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28908     Document Type: Erratum

References (32)

1. Parisi GF, Di Dio G, Franzonello C, Gennaro A, Rotolo N, Lionetti E, Leonardi S. Liver disease in cystic fibrosis: an update. Hepat Mon 2013;13:e11215.
2. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD; American Association for the Study of Liver Diseases. Liver biopsy. Hepatology 2009;49:1017-1044.
3. Lewindon PJ, Ramm GA. Cystic fibrosis-cirrhosis, portal hypertension, and liver biopsy: reply. Hepatology 2011;53:1065-1066.
4. Ovchinsky N, Moreira RK, Lefkowitch JH, Lavine JE. Liver biopsy in modern clinical practice: a pediatric point-of-view. Adv Anat Pathol 2012;19:250-262.
5. Lewindon PJ, Shepherd RW, Walsh MJ, Greer RM, Williamson R, Pereira TN, et al. Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy. Hepatology 2011;53:193-201.
6. Huang JF, Hsieh MY, Dai CY, Hou NJ, Lee LP, Lin ZY, et al. The incidence and risks of liver biopsy in non-cirrhotic patients: An evaluation of 3806 biopsies. Gut 2007;56:736-737.
7. Falck-Ytter Y, McCullough AJ. The risks of percutaneous liver biopsy. Hepatology 2001;33:764.
8. Westheim BH, Ostensen AB, Aagenaes I, Sanengen T, Almaas R. Evaluation of risk factors for bleeding after liver biopsy in children. J Pediatr Gastroenterol Nutr 2012;55:82-87.
9. El-Shabrawi MH, El-Karaksy HM, Okahsa SH, Kamal NM, El-Batran G, Badr KA. Outpatient blind percutaneous liver biopsy in infants and children: is it safe? Saudi J Gastroenterol 2012;18:26-33.
10. Lachaux A, Le Gall C, Chambon M, Regnier F, Loras-Duclaux I, Bouvier R, et al. Complications of percutaneous liver biopsy in infants and children. Eur J Pediatr 1995;154:621-623.
11. Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008;134:8-14.
12. Rockey DC, Bissell DM. Noninvasive measures of liver fibrosis. Hepatology 2006;43:S113-120.
13. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526.
14. Jin W, Lin Z, Xin Y, Jiang X, Dong Q, Xuan S. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterol 2012;12:14.
15. Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 2011;53:726-736.
16. McGoogan KE, Smith PB, Choi SS, Berman W, Jhaveri R. Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis. J Pediatr Gastroenterol Nutr 2010;50:344-346.
17. Grieve A, Makin E, Davenport M. Aspartate aminotransferase-to-platelet ratio index (APRI) in infants with biliary atresia: prognostic value at presentation. J Pediatr Surg 2013;48:789-795.
18. Kim SY, Seok JY, Han SJ, Koh H. Assessment of liver fibrosis and cirrhosis by aspartate aminotransferase-to-platelet ratio index in children with biliary atresia. J Pediatr Gastroenterol Nutr 2010;51:198-202.
19. Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 2006;43:1317-1325.
20. Bedossa P. [Presentation of a grid for computer analysis for compilation of histopathologic lesions in chronic viral hepatitis C. Cooperative study of the METAVIR group]. [Article in French]. Ann Pathol 1993;13:260-265.
21. Pereira TN, Lewindon PJ, Smith JL, Murphy TL, Lincoln DJ, Shepherd RW, Ramm GA. Serum markers of hepatic fibrogenesis in cystic fibrosis liver disease. J Hepatol 2004;41:576-583.
22. Cook NL, Pereira TN, Lewindon PJ, Shepherd RW, Ramm GA. Circulating MicroRNAs as noninvasive diagnostic biomarkers of liver disease in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 2015;60:247-254.
23. de Ledinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, et al. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 2007;45:443-450.
24. Malbrunot-Wagner AC, Bridoux L, Nousbaum JB, Riou C, Dirou A, Ginies JL, et al. Transient elastography and portal hypertension in pediatric patients with cystic fibrosis transient elastography and cystic fibrosis. J Cyst Fibros 2011;10:338-342.
25. Menten R, Leonard A, Clapuyt P, Vincke P, Nicolae AC, Lebecque P. Transient elastography in patients with cystic fibrosis. Pediatr Radiol 2010;40:1231-1235.
26. Witters P, De Boeck K, Dupont L, Proesmans M, Vermeulen F, Servaes R, et al. Non-invasive liver elastography (Fibroscan) for detection of cystic fibrosis-associated liver disease. J Cyst Fibros 2009;8:392-399.
27. Mueller-Abt PR, Frawley KJ, Greer RM, Lewindon PJ. Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver disease. J Cyst Fibros 2008;7:215-221.
28. Li J, Gordon SC, Rupp LB, Zhang T, Boscarino JA, Vijayadeva V, et al. The validity of serum markers for fibrosis staging in chronic hepatitis B and C. J Viral Hepat 2014;21:930-937.
29. Sokol RJ, Durie PR. Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. J Pediatr Gastroenterol Nutr 1999;28(Suppl 1):S1-S13.
30. Kitson MT, Kemp WW, Iser DM, Paul E, Wilson JW, Roberts SK. Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease. Liver Int 2013;33:698-705.
31. Breton E, Bridoux-Henno L, Guyader D, Danielou H, Jouan H, Beuchee A, et al. [Value of transient elastography in noninvasive assessment in children's hepatic fibrosis]. [Article in French]. Arch Pediatr 2009;16:1005-1010.
32. Karlas T, Neuschulz M, Oltmanns A, Guttler A, Petroff D, Wirtz H, et al. Non-invasive evaluation of cystic fibrosis related liver disease in adults with ARFI, transient elastography and different fibrosis scores. PLoS One 2012;7:e42139.